首页 > 最新文献

四川大学学报(医学版)最新文献

英文 中文
[Development of a Reverse Transcription Loop-Mediated Isothermal Amplification Assay for the Detection of Genogroup Ⅱ Norovirus]. [建立一种逆转录环介导的等温扩增方法检测基因群Ⅱ诺如病毒]。
Q3 Medicine Pub Date : 2025-11-20 DOI: 10.12182/20251160201
Yi Liu, Jing Zhang, Chao Zhao, Juan Wang

Objective: To establish a rapid testing method for genogroup Ⅱ (GⅡ) norovirus based on reverse transcription loop-mediated isothermal amplification (RT-LAMP).

Methods: The conserved region of norovirus was screened using the genomic data from the National Center for Biotechnology Information (NCBI) database, and specific primers were designed using the online software Primer Explorer V5. The testing system was established through optimization of experimental conditions, including reaction temperature, MgSO4 concentration, dNTP concentration, etc. The sensitivity and specificity of the method were evaluated. The optimized testing method was used to analyze clinical stool samples, and the results were compared with those of a commercially available kit.

Results: The established testing method exhibited high specificity, showing no cross-reactivity with adenovirus, human enterovirus, or rotavirus. The testing method also exhibited high sensitivity, with a detection limit of 51 copies/μL. The turnaround time was 45 min. For 34 stool samples from patients infected with norovirus, the testing results were highly consistent with those of the commercial kit, with a sensitivity of 100%, a specificity of 83.33%, and an area under the receiver operating characteristic (ROC) curve of 0.97 (95% CI: 0.92-1.00), indicating the high accuracy and reliability of the testing method.

Conclusion: In this study, we successfully developed an RT-LAMP-based testing method for GⅡ norovirus, which exhibits excellent sensitivity, specificity, and practical performance in clinical sample testing, making it suitable for use in primary care laboratories and for rapid testing in field settings.

目的:建立一种基于逆转录环介导等温扩增(RT-LAMP)的基因群Ⅱ(GⅡ)诺如病毒快速检测方法。方法:利用美国国家生物技术信息中心(National Center for Biotechnology Information, NCBI)数据库的基因组数据筛选诺如病毒的保守区,利用Primer Explorer V5软件设计特异性引物。通过优化实验条件,包括反应温度、MgSO4浓度、dNTP浓度等,建立了测试系统。评价了该方法的敏感性和特异性。采用优化后的检测方法对临床粪便样本进行分析,并与市售试剂盒的结果进行比较。结果:所建立的检测方法特异性高,与腺病毒、人肠道病毒、轮状病毒无交叉反应。检测限为51个拷贝/μL,灵敏度较高。周转时间为45分钟。34例诺如病毒感染患者粪便标本的检测结果与市售试剂盒的检测结果高度一致,灵敏度为100%,特异性为83.33%,受试者工作特征(ROC)曲线下面积为0.97 (95% CI: 0.92-1.00),表明该检测方法具有较高的准确性和可靠性。结论:在本研究中,我们成功开发了一种基于rt - lamp的GⅡ诺如病毒检测方法,该方法在临床样品检测中具有良好的灵敏度、特异性和实用性,适用于初级保健实验室和现场快速检测。
{"title":"[Development of a Reverse Transcription Loop-Mediated Isothermal Amplification Assay for the Detection of Genogroup Ⅱ Norovirus].","authors":"Yi Liu, Jing Zhang, Chao Zhao, Juan Wang","doi":"10.12182/20251160201","DOIUrl":"10.12182/20251160201","url":null,"abstract":"<p><strong>Objective: </strong>To establish a rapid testing method for genogroup Ⅱ (GⅡ) norovirus based on reverse transcription loop-mediated isothermal amplification (RT-LAMP).</p><p><strong>Methods: </strong>The conserved region of norovirus was screened using the genomic data from the National Center for Biotechnology Information (NCBI) database, and specific primers were designed using the online software Primer Explorer V5. The testing system was established through optimization of experimental conditions, including reaction temperature, MgSO<sub>4</sub> concentration, dNTP concentration, etc. The sensitivity and specificity of the method were evaluated. The optimized testing method was used to analyze clinical stool samples, and the results were compared with those of a commercially available kit.</p><p><strong>Results: </strong>The established testing method exhibited high specificity, showing no cross-reactivity with adenovirus, human enterovirus, or rotavirus. The testing method also exhibited high sensitivity, with a detection limit of 51 copies/μL. The turnaround time was 45 min. For 34 stool samples from patients infected with norovirus, the testing results were highly consistent with those of the commercial kit, with a sensitivity of 100%, a specificity of 83.33%, and an area under the receiver operating characteristic (ROC) curve of 0.97 (95% CI: 0.92-1.00), indicating the high accuracy and reliability of the testing method.</p><p><strong>Conclusion: </strong>In this study, we successfully developed an RT-LAMP-based testing method for GⅡ norovirus, which exhibits excellent sensitivity, specificity, and practical performance in clinical sample testing, making it suitable for use in primary care laboratories and for rapid testing in field settings.</p>","PeriodicalId":39321,"journal":{"name":"四川大学学报(医学版)","volume":"56 6","pages":"1691-1696"},"PeriodicalIF":0.0,"publicationDate":"2025-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12796918/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145971339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Identification and Underlying Mechanisms of Immune Cell- and Senescence-Related Biomarkers in Atrial Fibrillation]. 房颤中免疫细胞和衰老相关生物标志物的鉴定和潜在机制
Q3 Medicine Pub Date : 2025-11-20 DOI: 10.12182/20251160108
Wei Huang, Enzhao Liu, Huaying Fu

Objective: To investigate the molecular mechanisms of immune cells (ICs)- and senescence-related biomarkers in atrial fibrillation (AF).

Methods: In this study, immune cell-related genes (ICRGs) were obtained using weighted gene co-expression network analysis (WGCNA) based on the GSE2240 dataset. Subsequently, the intersection of ICRGs, senescence-related genes (SRGs), and differentially expressed genes (DEGs) derived from differential expression analysis between AF and sinus rhythm (SR) groups was obtained to screen candidate genes. Biomarkers were further identified using the least absolute shrinkage and selection operator (LASSO) algorithm and validated in the GSE115571 dataset. Gene set enrichment analysis (GSEA), GeneMANIA network construction, molecular regulatory network construction, and molecular docking were performed to investigate the molecular mechanisms of the biomarkers in AF. A total of 8 male Sprague-Dawley rats of 87 weeks old and weighing 632-656 g were randomly assigned to the AF group and the sinus rhythm (SR) group (n = 4 per group). An AF rat model was established. The mRNA expression levels of myosin light chain kinase (MYLK) and insulin-like growth factor binding protein 2 (IGFBP2) in rat myocardial tissue were measured using reverse transcription quantitative polymerase chain reaction (RT-qPCR).

Results: Two biomarkers, MYLK and IGFBP2, were identified. GSEA revealed that MYLK was significantly enriched in the olfactory transduction pathway, whereas IGFBP2 was significantly enriched in the extracellular matrix-receptor interaction pathway. The GeneMANIA network demonstrated functional similarity between these biomarkers and 20 other genes. In addition, MYLK was regulated by 28 transcription factors (TFs) and 41 microRNAs (miRNAs), whereas IGFBP2 was regulated by 63 TFs and 4 miRNAs, including TAF1 and MIRT020526. Drug prediction analysis indicated that only MYLK had potential interactions with 3 drugs, among which Tozasertib exhibited the strongest binding affinity to MYLK, with a binding energy of -7.8 kcal/mol. RT-qPCR results showed that IGFBP2 mRNA expression was upregulated and MYLK mRNA expression was downregulated in myocardial tissue of rats in the AF group compared with the SR group (both P < 0.05).

Conclusion: In this study, MYLK and IGFBP2 are identified as AF-related biomarkers, and their potential molecular mechanisms are elucidated, providing new theoretical insights into AF research.

目的:探讨免疫细胞(ICs)和衰老相关生物标志物在房颤(AF)中的分子机制。方法:本研究基于GSE2240数据集,采用加权基因共表达网络分析(WGCNA)获得免疫细胞相关基因(ICRGs)。随后,获得ICRGs、衰老相关基因(SRGs)和AF组与窦性心律(SR)组差异表达分析得出的差异表达基因(DEGs)的交集,筛选候选基因。使用最小绝对收缩和选择算子(LASSO)算法进一步识别生物标志物,并在GSE115571数据集中进行验证。采用基因集富集分析(GSEA)、GeneMANIA网络构建、分子调控网络构建、分子对接等方法研究AF生物标志物的分子机制。选取87周龄、体重632 ~ 656 g的雄性Sprague-Dawley大鼠8只,随机分为AF组和窦性心律(SR)组(每组4只)。建立房颤大鼠模型。采用逆转录定量聚合酶链式反应(RT-qPCR)检测大鼠心肌组织中肌球蛋白轻链激酶(MYLK)和胰岛素样生长因子结合蛋白2 (IGFBP2) mRNA表达水平。结果:鉴定出MYLK和IGFBP2两种生物标志物。GSEA显示MYLK在嗅觉转导通路中显著富集,而IGFBP2在细胞外基质-受体相互作用通路中显著富集。GeneMANIA网络证明了这些生物标记物与其他20个基因之间的功能相似性。此外,MYLK受28个转录因子(TFs)和41个microrna (miRNAs)调控,而IGFBP2受63个转录因子和4个mirna调控,包括TAF1和MIRT020526。药物预测分析表明,只有MYLK与3种药物存在潜在的相互作用,其中Tozasertib与MYLK的结合亲和力最强,结合能为-7.8 kcal/mol。RT-qPCR结果显示,与SR组相比,AF组大鼠心肌组织IGFBP2 mRNA表达上调,MYLK mRNA表达下调(P < 0.05)。结论:本研究确定MYLK和IGFBP2为房颤相关生物标志物,并阐明其潜在的分子机制,为房颤研究提供新的理论见解。
{"title":"[Identification and Underlying Mechanisms of Immune Cell- and Senescence-Related Biomarkers in Atrial Fibrillation].","authors":"Wei Huang, Enzhao Liu, Huaying Fu","doi":"10.12182/20251160108","DOIUrl":"10.12182/20251160108","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the molecular mechanisms of immune cells (ICs)- and senescence-related biomarkers in atrial fibrillation (AF).</p><p><strong>Methods: </strong>In this study, immune cell-related genes (ICRGs) were obtained using weighted gene co-expression network analysis (WGCNA) based on the GSE2240 dataset. Subsequently, the intersection of ICRGs, senescence-related genes (SRGs), and differentially expressed genes (DEGs) derived from differential expression analysis between AF and sinus rhythm (SR) groups was obtained to screen candidate genes. Biomarkers were further identified using the least absolute shrinkage and selection operator (LASSO) algorithm and validated in the GSE115571 dataset. Gene set enrichment analysis (GSEA), GeneMANIA network construction, molecular regulatory network construction, and molecular docking were performed to investigate the molecular mechanisms of the biomarkers in AF. A total of 8 male Sprague-Dawley rats of 87 weeks old and weighing 632-656 g were randomly assigned to the AF group and the sinus rhythm (SR) group (<i>n</i> = 4 per group). An AF rat model was established. The mRNA expression levels of myosin light chain kinase (MYLK) and insulin-like growth factor binding protein 2 (IGFBP2) in rat myocardial tissue were measured using reverse transcription quantitative polymerase chain reaction (RT-qPCR).</p><p><strong>Results: </strong>Two biomarkers, MYLK and IGFBP2, were identified. GSEA revealed that MYLK was significantly enriched in the olfactory transduction pathway, whereas IGFBP2 was significantly enriched in the extracellular matrix-receptor interaction pathway. The GeneMANIA network demonstrated functional similarity between these biomarkers and 20 other genes. In addition, MYLK was regulated by 28 transcription factors (TFs) and 41 microRNAs (miRNAs), whereas IGFBP2 was regulated by 63 TFs and 4 miRNAs, including TAF1 and MIRT020526. Drug prediction analysis indicated that only MYLK had potential interactions with 3 drugs, among which Tozasertib exhibited the strongest binding affinity to MYLK, with a binding energy of -7.8 kcal/mol. RT-qPCR results showed that <i>IGFBP2</i> mRNA expression was upregulated and <i>MYLK</i> mRNA expression was downregulated in myocardial tissue of rats in the AF group compared with the SR group (both <i>P</i> < 0.05).</p><p><strong>Conclusion: </strong>In this study, MYLK and IGFBP2 are identified as AF-related biomarkers, and their potential molecular mechanisms are elucidated, providing new theoretical insights into AF research.</p>","PeriodicalId":39321,"journal":{"name":"四川大学学报(医学版)","volume":"56 6","pages":"1612-1619"},"PeriodicalIF":0.0,"publicationDate":"2025-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12796885/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145970996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Targeting Regulatory T Cells to Remodel Peripheral Immune Tolerance: Research Advances and Future Directions]. [靶向调节性T细胞重塑外周免疫耐受:研究进展和未来方向]。
Q3 Medicine Pub Date : 2025-11-20 DOI: 10.12182/20251160301
Wei Zhang, Zhenhong Li, Hantian Liang, Hao Cheng, Dunfang Zhang

Regulatory T cells (Tregs) are the most important population of immune cells in maintaining peripheral immune tolerance in the body. Targeting Tregs to rebuild peripheral immune tolerance has shown broad potential for application in the treatment of various inflammatory diseases, such as autoimmune diseases, allergic disorders, graft-versus-host disease, and organ transplant rejection. However, substantial challenges remain in translating Treg-based therapies into clinical practice. In this review, we first summarize the discovery of Tregs and the principal mechanisms through which Tregs inhibit immune responses. Then, the research progress in polyclonal Treg-based therapy, antigen-specific Treg-based therapy, and low-dose interleukin-2 (IL-2) therapy and the implementation status of clinical trials of Treg therapies were comprehensively summarized. Finally, four issues, including maintaining the stability of Tregs, preparing autoantigen-specific Tregs, such as chimeric antigen receptor (CAR)-Tregs and T-cell receptor (TCR)-Tregs, reshaping the inflammatory microenvironment of diseases, and minimizing the potential adverse effects of Treg therapies, were highlighted as the bottleneck problems in the clinical translation of Treg therapies and priority directions for future research.

调节性T细胞(Regulatory T cells, Tregs)是维持机体外周免疫耐受最重要的免疫细胞群。靶向Tregs重建外周免疫耐受在治疗各种炎症性疾病,如自身免疫性疾病、过敏性疾病、移植物抗宿主病和器官移植排斥反应等方面显示出广泛的应用潜力。然而,将treg为基础的治疗方法转化为临床实践仍然存在重大挑战。在这篇综述中,我们首先总结了Tregs的发现和Tregs抑制免疫反应的主要机制。然后,对Treg多克隆治疗、抗原特异性Treg治疗、低剂量白介素-2 (IL-2)治疗的研究进展及Treg治疗的临床试验实施情况进行了全面总结。最后,强调了维持Treg的稳定性、制备自身抗原特异性Treg,如嵌合抗原受体(CAR)-Tregs和t细胞受体(TCR)-Tregs、重塑疾病炎症微环境、减少Treg治疗的潜在不良反应等4个问题是Treg治疗临床转化的瓶颈问题和未来研究的重点方向。
{"title":"[Targeting Regulatory T Cells to Remodel Peripheral Immune Tolerance: Research Advances and Future Directions].","authors":"Wei Zhang, Zhenhong Li, Hantian Liang, Hao Cheng, Dunfang Zhang","doi":"10.12182/20251160301","DOIUrl":"10.12182/20251160301","url":null,"abstract":"<p><p>Regulatory T cells (Tregs) are the most important population of immune cells in maintaining peripheral immune tolerance in the body. Targeting Tregs to rebuild peripheral immune tolerance has shown broad potential for application in the treatment of various inflammatory diseases, such as autoimmune diseases, allergic disorders, graft-versus-host disease, and organ transplant rejection. However, substantial challenges remain in translating Treg-based therapies into clinical practice. In this review, we first summarize the discovery of Tregs and the principal mechanisms through which Tregs inhibit immune responses. Then, the research progress in polyclonal Treg-based therapy, antigen-specific Treg-based therapy, and low-dose interleukin-2 (IL-2) therapy and the implementation status of clinical trials of Treg therapies were comprehensively summarized. Finally, four issues, including maintaining the stability of Tregs, preparing autoantigen-specific Tregs, such as chimeric antigen receptor (CAR)-Tregs and T-cell receptor (TCR)-Tregs, reshaping the inflammatory microenvironment of diseases, and minimizing the potential adverse effects of Treg therapies, were highlighted as the bottleneck problems in the clinical translation of Treg therapies and priority directions for future research.</p>","PeriodicalId":39321,"journal":{"name":"四川大学学报(医学版)","volume":"56 6","pages":"1459-1466"},"PeriodicalIF":0.0,"publicationDate":"2025-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12796923/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145971208","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Correlation of Serum Neuron-Specific Enolase, Angiopoietin-1, and Angiopoietin-Like Protein-3 With Disease Severity and Their Prognostic Value in Patients With Cerebral Infarction]. [脑梗死患者血清神经元特异性烯醇化酶、血管生成素-1和血管生成素样蛋白-3与疾病严重程度及其预后价值的相关性]。
Q3 Medicine Pub Date : 2025-11-20 DOI: 10.12182/20251160506
Jianping Liu, Hui Gao, Yufan Liu
<p><strong>Objective: </strong>To investigate the association between the disease severity and prognosis of cerebral infarction patients and serum levels of neuron-specific enolase (NSE), angiopoietin-1 (Ang-1), and angiopoietin-like protein-3 (ANGPTL3).</p><p><strong>Methods: </strong>A total of 510 patients with cerebral infarction admitted to the Department of Neurology, the First People's Hospital of Jiujiang City, Jiangxi Province between February 2022 and May 2024 were enrolled. According to their disease severity, the patients were divided into a mild group (<i>n</i> = 192), a moderate group (<i>n</i> = 215), and a severe group (<i>n</i> = 103). After treatment, the patients were further divided into a good prognosis group (<i>n</i> = 384) and a poor prognosis group (<i>n</i> = 126). During the same period, 121 healthy individuals were included as a control group. During the same period, 121 healthy individuals were included in a control group. Serum levels of NSE, Ang-1, and ANGPTL3 of all patients were measured upon admission. The correlations between these biomarkers and disease severity were analyzed. The predictive value of each biomarker alone and that of the 3 biomarkers in combination for poor prognosis in patients with cerebral infarction were assessed using receiver operating characteristic (ROC) curves.</p><p><strong>Results: </strong>Serum NSE and ANGPTL3 levels in the severe group were significantly higher than those in the moderate and mild groups, whereas the serum Ang-1 levels in the severe group were significantly lower than those in the moderate and mild groups (all <i>P</i> < 0.05). Spearman correlation analysis showed that serum NSE and ANGPTL3 levels were positively correlated with disease severity (<i>r</i> = 0.179 and 0.313, respectively, <i>P</i> < 0.05), while serum Ang-1 levels were negatively correlated with disease severity (<i>r</i> = -0.187, <i>P</i> < 0.05). Prognostic analysis revealed that serum NSE and ANGPTL3 levels were higher, while serum Ang-1 levels were lower, in the poor prognosis group compared with the good prognosis group (all <i>P</i> < 0.05). Multivariate logistic regression revealed that serum levels of NSE (odds ratio [OR] = 1.228, 95% CI: 1.146-1.316), Ang-1 (OR = 0.059, 95% CI: 0.020-0.178), and ANGPTL3 (OR = 1.334, 95% CI: 1.256-1.417) were major factors associated with prognosis in patients with cerebral infarction (all <i>P</i> < 0.05). ROC curves showed that serum NSE, Ang-1, and ANGPTL3 levels in combination yielded an area under the curve (AUC) of 0.904 (95% CI: 0.871-0.936), with a sensitivity of 79.40% and a specificity of 89.60%. The Hosmer-Lemeshow test of the model showed a good predictive performance (<i>χ</i> <sup>2</sup> = 7.423, <i>P</i> = 0.492).</p><p><strong>Conclusion: </strong>The severity and prognosis of cerebral infarction patients are strongly correlated with high serum NSE and ANGPTL3 levels and low Ang-1 levels. Monitoring changes in these 3 biomarkers may inform c
目的:探讨脑梗死患者血清神经元特异性烯醇化酶(NSE)、血管生成素-1 (Ang-1)、血管生成素样蛋白-3 (ANGPTL3)水平与病情严重程度及预后的关系。方法:选取2022年2月- 2024年5月江西省九江市第一人民医院神经内科收治的510例脑梗死患者。根据病情严重程度将患者分为轻度组(n = 192)、中度组(n = 215)和重度组(n = 103)。治疗后将患者进一步分为预后良好组(384例)和预后不良组(126例)。在同一时期,121名健康个体被纳入对照组。在同一时期,121名健康个体被纳入对照组。入院时测定所有患者血清NSE、ang1、ANGPTL3水平。分析了这些生物标志物与疾病严重程度之间的相关性。采用受试者工作特征(ROC)曲线评估每种生物标志物单独使用及3种生物标志物联合使用对脑梗死患者不良预后的预测价值。结果:重症组血清NSE、ANGPTL3水平显著高于中度和轻度组,重症组血清ang1水平显著低于中度和轻度组(均P < 0.05)。Spearman相关分析显示,血清NSE、ANGPTL3水平与疾病严重程度呈正相关(r = 0.179、0.313,P < 0.05),血清ang1水平与疾病严重程度呈负相关(r = -0.187, P < 0.05)。预后分析显示,预后不良组血清NSE、ANGPTL3水平高于预后良好组,血清ang1水平低于预后良好组(均P < 0.05)。多因素logistic回归分析显示,血清NSE水平(比值比[OR] = 1.228, 95% CI: 1.146 ~ 1.316)、ang1水平(比值比[OR] = 0.059, 95% CI: 0.020 ~ 0.178)、ANGPTL3水平(比值比[OR] = 1.334, 95% CI: 1.259 ~ 1.417)是影响脑梗死患者预后的主要因素(均P < 0.05)。ROC曲线显示,血清NSE、ang1、ANGPTL3水平联合检测的曲线下面积(AUC)为0.904 (95% CI: 0.871 ~ 0.936),敏感性为79.40%,特异性为89.60%。模型的Hosmer-Lemeshow检验显示预测效果较好(χ 2 = 7.423, P = 0.492)。结论:脑梗死患者的严重程度和预后与血清NSE、ANGPTL3水平高、ang1水平低密切相关。监测这3种生物标志物的变化可能为脑梗死患者的临床治疗提供信息。
{"title":"[Correlation of Serum Neuron-Specific Enolase, Angiopoietin-1, and Angiopoietin-Like Protein-3 With Disease Severity and Their Prognostic Value in Patients With Cerebral Infarction].","authors":"Jianping Liu, Hui Gao, Yufan Liu","doi":"10.12182/20251160506","DOIUrl":"10.12182/20251160506","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To investigate the association between the disease severity and prognosis of cerebral infarction patients and serum levels of neuron-specific enolase (NSE), angiopoietin-1 (Ang-1), and angiopoietin-like protein-3 (ANGPTL3).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;A total of 510 patients with cerebral infarction admitted to the Department of Neurology, the First People's Hospital of Jiujiang City, Jiangxi Province between February 2022 and May 2024 were enrolled. According to their disease severity, the patients were divided into a mild group (&lt;i&gt;n&lt;/i&gt; = 192), a moderate group (&lt;i&gt;n&lt;/i&gt; = 215), and a severe group (&lt;i&gt;n&lt;/i&gt; = 103). After treatment, the patients were further divided into a good prognosis group (&lt;i&gt;n&lt;/i&gt; = 384) and a poor prognosis group (&lt;i&gt;n&lt;/i&gt; = 126). During the same period, 121 healthy individuals were included as a control group. During the same period, 121 healthy individuals were included in a control group. Serum levels of NSE, Ang-1, and ANGPTL3 of all patients were measured upon admission. The correlations between these biomarkers and disease severity were analyzed. The predictive value of each biomarker alone and that of the 3 biomarkers in combination for poor prognosis in patients with cerebral infarction were assessed using receiver operating characteristic (ROC) curves.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Serum NSE and ANGPTL3 levels in the severe group were significantly higher than those in the moderate and mild groups, whereas the serum Ang-1 levels in the severe group were significantly lower than those in the moderate and mild groups (all &lt;i&gt;P&lt;/i&gt; &lt; 0.05). Spearman correlation analysis showed that serum NSE and ANGPTL3 levels were positively correlated with disease severity (&lt;i&gt;r&lt;/i&gt; = 0.179 and 0.313, respectively, &lt;i&gt;P&lt;/i&gt; &lt; 0.05), while serum Ang-1 levels were negatively correlated with disease severity (&lt;i&gt;r&lt;/i&gt; = -0.187, &lt;i&gt;P&lt;/i&gt; &lt; 0.05). Prognostic analysis revealed that serum NSE and ANGPTL3 levels were higher, while serum Ang-1 levels were lower, in the poor prognosis group compared with the good prognosis group (all &lt;i&gt;P&lt;/i&gt; &lt; 0.05). Multivariate logistic regression revealed that serum levels of NSE (odds ratio [OR] = 1.228, 95% CI: 1.146-1.316), Ang-1 (OR = 0.059, 95% CI: 0.020-0.178), and ANGPTL3 (OR = 1.334, 95% CI: 1.256-1.417) were major factors associated with prognosis in patients with cerebral infarction (all &lt;i&gt;P&lt;/i&gt; &lt; 0.05). ROC curves showed that serum NSE, Ang-1, and ANGPTL3 levels in combination yielded an area under the curve (AUC) of 0.904 (95% CI: 0.871-0.936), with a sensitivity of 79.40% and a specificity of 89.60%. The Hosmer-Lemeshow test of the model showed a good predictive performance (&lt;i&gt;χ&lt;/i&gt; &lt;sup&gt;2&lt;/sup&gt; = 7.423, &lt;i&gt;P&lt;/i&gt; = 0.492).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;The severity and prognosis of cerebral infarction patients are strongly correlated with high serum NSE and ANGPTL3 levels and low Ang-1 levels. Monitoring changes in these 3 biomarkers may inform c","PeriodicalId":39321,"journal":{"name":"四川大学学报(医学版)","volume":"56 6","pages":"1647-1652"},"PeriodicalIF":0.0,"publicationDate":"2025-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12796884/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145971366","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Optimization of Comprehensive Prevention and Control Strategies for Myopia From the Persepctive of the Social Ecological Systems Theory]. [社会生态系统理论视角下的近视综合防控策略优化]。
Q3 Medicine Pub Date : 2025-11-20 DOI: 10.12182/20251160601
Zewei Chen, Mengrong Zhu, Lin Yue

Myopia is a global public health challenge. It is projected that the myopia rate in China will reach 80% by 2050, which will cause visual impairment, psychological problems, and economic burdens. The effective prevention and control of myopia are critical for improving the health of children and adolescents and reducing socioeconomic burdens. The existing myopia prevention and control strategies include individual interventions and school-based group interventions, which have shown remarkable results. However, limitations such as insufficient compliance, high technical costs, and regional differences have limited their effects. The policy-advocated five-in-one prevention and control system (consisting of the government, schools, families, health care, and society) faces challenges in effectively integrating multi-field strategies due to poor interdepartmental coordination, uneven resource distribution, and the lack of assessment mechanisms. Through a systematic literature review, this paper examines research on myopia prevention and control across multiple fields such as medicine, education, technology, and policy. Based on the micro, meso, and macro perspectives of the Social Ecological Systems Theory (SET), the advantages and limitations of strategies are analyzed, and optimization pathways are explored.

近视是一项全球性的公共卫生挑战。预计到2050年,中国的近视率将达到80%,这将造成视力损害、心理问题和经济负担。有效预防和控制近视对于提高儿童青少年的健康水平和减轻社会经济负担至关重要。现有的近视防治策略包括个体干预和校本团体干预,并取得了显著的效果。然而,不充分的遵守、高技术成本和区域差异等限制限制了它们的效果。政策倡导的由政府、学校、家庭、卫生保健和社会组成的五位一体的防控体系,由于部门间协调不力、资源分配不均和缺乏评估机制,在有效整合多领域战略方面面临挑战。本文通过系统的文献综述,从医学、教育、技术、政策等多个领域对近视防治的研究进行了梳理。基于社会生态系统理论(SET)的微观、中观和宏观视角,分析了策略的优势和局限性,并探索了优化路径。
{"title":"[Optimization of Comprehensive Prevention and Control Strategies for Myopia From the Persepctive of the Social Ecological Systems Theory].","authors":"Zewei Chen, Mengrong Zhu, Lin Yue","doi":"10.12182/20251160601","DOIUrl":"10.12182/20251160601","url":null,"abstract":"<p><p>Myopia is a global public health challenge. It is projected that the myopia rate in China will reach 80% by 2050, which will cause visual impairment, psychological problems, and economic burdens. The effective prevention and control of myopia are critical for improving the health of children and adolescents and reducing socioeconomic burdens. The existing myopia prevention and control strategies include individual interventions and school-based group interventions, which have shown remarkable results. However, limitations such as insufficient compliance, high technical costs, and regional differences have limited their effects. The policy-advocated five-in-one prevention and control system (consisting of the government, schools, families, health care, and society) faces challenges in effectively integrating multi-field strategies due to poor interdepartmental coordination, uneven resource distribution, and the lack of assessment mechanisms. Through a systematic literature review, this paper examines research on myopia prevention and control across multiple fields such as medicine, education, technology, and policy. Based on the micro, meso, and macro perspectives of the Social Ecological Systems Theory (SET), the advantages and limitations of strategies are analyzed, and optimization pathways are explored.</p>","PeriodicalId":39321,"journal":{"name":"四川大学学报(医学版)","volume":"56 6","pages":"1506-1512"},"PeriodicalIF":0.0,"publicationDate":"2025-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12796907/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145971109","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Construction and Clinical Validation of a Risk Early Warning Model for Mechanical Ventilation-Associated Pneumonia in Older Patients With Lung Cancer]. 老年肺癌患者机械通气相关性肺炎风险预警模型的构建与临床验证
Q3 Medicine Pub Date : 2025-11-20 DOI: 10.12182/20251160205
Zhiyan Wang, Min Shi, Peng Zhao, Yu Zhou, Zhijian Zhang, Geping Qu, Xiangqun Fang

Objective: To establish and validate a risk prediction model for mechanical ventilator-associated pneumonia (VAP) in older patients with lung cancer.

Methods: A total of 548 older patients with lung cancer were enrolled between January 2022 and May 2025. Subsequently, the patients were divided into a training set (n = 384) and a validation set (n = 164) at a ratio of 7∶3. According to whether the patients developed VAP, the training set was further divided into a non-VAP subgroup (n = 231) and a VAP subgroup (n = 153), and the validation set was divided into a non-VAP subgroup (n = 99) and a VAP subgroup (n = 65). Multivariate stepwise logistic regression was conducted to identify the predictors of VAP in older patients with lung cancer, and a nomogram model was established accordingly. The model was validated using the receiver operating characteristic (ROC) curve and the calibration curve.

Results: A total of 153 participants (39.84%) in the training set and 65 participants (39.63%) in the validation set developed VAP. Univariate analysis revealed that such factors as age, lung cancer stage, mechanical ventilation duration, Acute Physiologic Assessment and Chronic Health Evaluation (APACHE) Ⅱ score, procalcitonin (PCT), pentraxin 3 (PTX3), retinol-binding protein (RBP), soluble triggering receptor expressed on myeloid cells-1 (STREM-1), and human cartilage glycoprotein-39 (YKL-40) were associated with VAP in older lung cancer patients (P < 0.05), and there was no multicollinearity. Multivariate logistic stepwise regression revealed that age (odds ratio [OR] = 1.182, 95% CI: 1.014-1.377), mechanical ventilation duration (OR = 3.929, 95% CI: 1.374-11.233), APACHE Ⅱ (OR = 1.770, 95% CI: 1.296-2.416), PTX3 (OR = 1.019, 95% CI: 1.007-1.030), RBP (OR = 1.150, 95% CI: 1.083-1.260), STREM-1 (OR = 1.168, 95% CI: 1.083-1.260) were predictors of VAP in older lung cancer patients (P < 0.05). A nomogram model was constructed with the following equation: Prob = 1/(1 + e-Y), Y = -43.147 + 0.167 × age + 1.368× mechanical ventilation duration + 0.571 × APACHE Ⅱ score + 0.019 × PTX3 + 0.140 × RBP + 0.155 × STREM-1. The area under the curve (AUC) of the ROC in the training set was 0.909 (95% CI: 0.878-0.940), and the AUC of the validation set was 0.843 (95% CI: 0.776-0.910). The average absolute error tested by the Bootstrap method was 0.03, indicating that the model showed a certain level of consistency during both the training and validation processes.

Conclusion: Age, mechanical ventilation duration, APACHE Ⅱ score, and serum levels of PTX3, RBP, and STREM-1 are all predictors for the occurrence of VAP in older lung cancer patients. The nomogram model constructed based on these factors demonstrates acceptable predictive performance.

目的:建立并验证老年肺癌患者机械呼吸机相关性肺炎(VAP)的风险预测模型。方法:在2022年1月至2025年5月期间,共有548例老年肺癌患者入组。将患者按7∶3的比例分为训练组(384例)和验证组(164例)。根据患者是否发生VAP,进一步将训练集分为非VAP亚组(n = 231)和VAP亚组(n = 153),将验证集分为非VAP亚组(n = 99)和VAP亚组(n = 65)。采用多因素逐步logistic回归分析老年肺癌患者VAP的预测因素,并建立相应的nomogram模型。采用受试者工作特征(ROC)曲线和标定曲线对模型进行验证。结果:训练集中153名参与者(39.84%)和验证集中65名参与者(39.63%)出现了VAP。单因素分析显示,年龄、肺癌分期、机械通气时间、急性生理评估与慢性健康评估(APACHE)Ⅱ评分、降钙素原(PCT)、pentraxin 3 (PTX3)、视黄醇结合蛋白(RBP)、骨髓细胞可溶性触发受体-1 (strem1)、人软骨糖蛋白-39 (YKL-40)与老年肺癌患者VAP相关(P < 0.05),且无多重共线性关系。多因素logistic逐步回归显示,年龄(比值比[OR] = 1.182, 95% CI: 1.014 ~ 1.377)、机械通气时间(OR = 3.929, 95% CI: 1.374 ~ 11.233)、APACHEⅡ(OR = 1.770, 95% CI: 1.296 ~ 2.416)、PTX3 (OR = 1.019, 95% CI: 1.007 ~ 1.030)、RBP (OR = 1.150, 95% CI: 1.083 ~ 1.260)、string -1 (OR = 1.168, 95% CI: 1.083 ~ 1.260)是老年肺癌患者VAP的预测因子(P < 0.05)。拟合公式为:Prob = 1/(1 + e-Y), Y = -43.147 + 0.167 ×年龄+ 1.368×机械通气时间+ 0.571 × APACHEⅡ评分+ 0.019 × PTX3 + 0.140 × RBP + 0.155 × stream -1。训练集的ROC曲线下面积(AUC)为0.909 (95% CI: 0.878 ~ 0.940),验证集的AUC为0.843 (95% CI: 0.776 ~ 0.910)。Bootstrap方法测试的平均绝对误差为0.03,说明模型在训练和验证过程中都表现出一定程度的一致性。结论:年龄、机械通气时间、APACHEⅡ评分、血清PTX3、RBP、STREM-1水平均是老年肺癌患者VAP发生的预测因子。基于这些因素构建的模态图模型具有良好的预测性能。
{"title":"[Construction and Clinical Validation of a Risk Early Warning Model for Mechanical Ventilation-Associated Pneumonia in Older Patients With Lung Cancer].","authors":"Zhiyan Wang, Min Shi, Peng Zhao, Yu Zhou, Zhijian Zhang, Geping Qu, Xiangqun Fang","doi":"10.12182/20251160205","DOIUrl":"10.12182/20251160205","url":null,"abstract":"<p><strong>Objective: </strong>To establish and validate a risk prediction model for mechanical ventilator-associated pneumonia (VAP) in older patients with lung cancer.</p><p><strong>Methods: </strong>A total of 548 older patients with lung cancer were enrolled between January 2022 and May 2025. Subsequently, the patients were divided into a training set (<i>n</i> = 384) and a validation set (<i>n</i> = 164) at a ratio of 7∶3. According to whether the patients developed VAP, the training set was further divided into a non-VAP subgroup (<i>n</i> = 231) and a VAP subgroup (<i>n</i> = 153), and the validation set was divided into a non-VAP subgroup (<i>n</i> = 99) and a VAP subgroup (<i>n</i> = 65). Multivariate stepwise logistic regression was conducted to identify the predictors of VAP in older patients with lung cancer, and a nomogram model was established accordingly. The model was validated using the receiver operating characteristic (ROC) curve and the calibration curve.</p><p><strong>Results: </strong>A total of 153 participants (39.84%) in the training set and 65 participants (39.63%) in the validation set developed VAP. Univariate analysis revealed that such factors as age, lung cancer stage, mechanical ventilation duration, Acute Physiologic Assessment and Chronic Health Evaluation (APACHE) Ⅱ score, procalcitonin (PCT), pentraxin 3 (PTX3), retinol-binding protein (RBP), soluble triggering receptor expressed on myeloid cells-1 (STREM-1), and human cartilage glycoprotein-39 (YKL-40) were associated with VAP in older lung cancer patients (<i>P</i> < 0.05), and there was no multicollinearity. Multivariate logistic stepwise regression revealed that age (odds ratio [OR] = 1.182, 95% CI: 1.014-1.377), mechanical ventilation duration (OR = 3.929, 95% CI: 1.374-11.233), APACHE Ⅱ (OR = 1.770, 95% CI: 1.296-2.416), PTX3 (OR = 1.019, 95% CI: 1.007-1.030), RBP (OR = 1.150, 95% CI: 1.083-1.260), STREM-1 (OR = 1.168, 95% CI: 1.083-1.260) were predictors of VAP in older lung cancer patients (<i>P</i> < 0.05). A nomogram model was constructed with the following equation: Prob = 1/(1 + e<sup>-Y</sup>), Y = -43.147 + 0.167 × age + 1.368× mechanical ventilation duration + 0.571 × APACHE Ⅱ score + 0.019 × PTX3 + 0.140 × RBP + 0.155 × STREM-1. The area under the curve (AUC) of the ROC in the training set was 0.909 (95% CI: 0.878-0.940), and the AUC of the validation set was 0.843 (95% CI: 0.776-0.910). The average absolute error tested by the Bootstrap method was 0.03, indicating that the model showed a certain level of consistency during both the training and validation processes.</p><p><strong>Conclusion: </strong>Age, mechanical ventilation duration, APACHE Ⅱ score, and serum levels of PTX3, RBP, and STREM-1 are all predictors for the occurrence of VAP in older lung cancer patients. The nomogram model constructed based on these factors demonstrates acceptable predictive performance.</p>","PeriodicalId":39321,"journal":{"name":"四川大学学报(医学版)","volume":"56 6","pages":"1620-1626"},"PeriodicalIF":0.0,"publicationDate":"2025-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12796911/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145971283","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Current Status and Effect Pathways of Knowledge, Attitude, and Practice of Medical Care and Prevention Integration Among Medical Professionals]. 医学专业人员医患结合的知识、态度和实践现状及影响途径
Q3 Medicine Pub Date : 2025-11-20 DOI: 10.12182/20251160104
Qiaosheng Li, Ting Wang, Weiyan Jian
<p><strong>Objective: </strong>To investigate the changes in knowledge, attitude, and practice (KAP) regarding the integration of medical care and prevention among medical professionals in medical institutions of pilot cities of the collaboration and integration of medical care and prevention, a national pilot program for infectious disease prevention and control, to examine the effect pathways, and to provide empirical evidence for promoting the implementation of the integration of medical care and prevention and improving relevant policies.</p><p><strong>Methods: </strong>The participants in this study were medical professionals involved in medical care and prevention integration work. The participants were all from medical institutions of pilot cities for the collaboration and integration of medical care and prevention. The study sample was selected through multi-stage sampling. A questionnaire based on the theoretical framework of the KAP model was designed. Two cross-sectional surveys were conducted-once before the initiation of the pilot program (baseline) and again 12 months after implementation (after implementation). After propensity score matching (PSM), descriptive statistics and hypothesis testing were used to statistically analyze the questionnaire data. In addition, a structural equation model (SEM) was applied to assess the current status and effect pathways of the participants' KAP regarding the integration of medical care and prevention.</p><p><strong>Results: </strong>A total of 11472 responses were collected, and 10627 were included in analysis after PSM, including 5007 before the implementation of the policy and 5620 after the implementation of the policy. No significant differences were observed in demographic variables between the two samples. Baseline scores for knowledge, attitude, and practice regarding the integration of medical care and prevention were 13.32 ± 0.05, 15.62 ± 0.04, and 6.37 ± 0.02 respectively, while the scores at the end of the study were 13.69, 15.74, and 6.51, respectively, all show an increase to a certain degree (<i>P</i> < 0.05). Stratified analysis by institution level revealed relatively significant improvements in knowledge and practice (<i>P</i> < 0.05), but no significant improvement in attitudes (<i>P</i> > 0.05) among medical professionals. Medical professionals in primary medical institutions generally demonstrated superior knowledge, attitudes, and practice frequency compared with those in secondary and tertiary hospitals (<i>P</i> < 0.001). No significant changes in KAP were observed among medical professionals in secondary hospitals (<i>P</i> > 0.05). Regarding the integration of medical care and prevention, the effect of knowledge on practice (standardized path coefficient = 0.496, 95% CI: 0.482, 0.508) was stronger than that of attitude on practice (standardized path coefficient = 0.267, 95% CI: 0.244, 0.290). The direct effect of knowledge on practice (78.0%) was greater than the indir
摘要目的:调查国家传染病防治协同结合试点城市医疗机构医务人员对医疗预防结合的知识、态度和行为(KAP)变化情况,探讨影响途径;并为促进医疗预防一体化的实施和完善相关政策提供实证依据。方法:本研究的研究对象为从事医防结合工作的医疗专业人员。与会人员均来自医疗预防协同融合试点城市医疗机构。研究样本采用多阶段抽样方法选取。基于KAP模型的理论框架,设计了问卷。进行了两次横断面调查,一次是在试点计划启动之前(基线),另一次是在实施后12个月(实施后)。采用倾向得分匹配(PSM)、描述性统计和假设检验对问卷数据进行统计分析。此外,采用结构方程模型(SEM)评估了被试在医疗预防一体化方面的KAP现状及其作用途径。结果:共收集问卷11472份,PSM后纳入分析问卷10627份,其中政策实施前5007份,政策实施后5620份。两个样本的人口统计学变量没有显著差异。医防结合知识、态度、行为的基线得分分别为13.32±0.05、15.62±0.04、6.37±0.02,研究结束时得分分别为13.69、15.74、6.51,均有一定程度的提高(P < 0.05)。机构层次分层分析显示,医疗专业人员在知识和实践方面有相对显著的改善(P < 0.05),但在态度方面无显著改善(P < 0.05)。基层医疗机构医务人员的知识、态度和执业频次普遍优于二级和三级医院(P < 0.001)。二级医院医务人员的KAP无显著变化(P < 0.05)。在医防一体化方面,知识对实践的影响(标准化路径系数= 0.496,95% CI: 0.482, 0.508)大于态度对实践的影响(标准化路径系数= 0.267,95% CI: 0.244, 0.290)。知识对实践的直接影响(78.0%)大于态度介导的间接影响(22.0%)。结论:国家传染病防控医防协同结合试点项目对提高医务人员医防结合知识知晓度具有积极作用。医疗预防一体化知识是影响实践的首要因素。
{"title":"[Current Status and Effect Pathways of Knowledge, Attitude, and Practice of Medical Care and Prevention Integration Among Medical Professionals].","authors":"Qiaosheng Li, Ting Wang, Weiyan Jian","doi":"10.12182/20251160104","DOIUrl":"10.12182/20251160104","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To investigate the changes in knowledge, attitude, and practice (KAP) regarding the integration of medical care and prevention among medical professionals in medical institutions of pilot cities of the collaboration and integration of medical care and prevention, a national pilot program for infectious disease prevention and control, to examine the effect pathways, and to provide empirical evidence for promoting the implementation of the integration of medical care and prevention and improving relevant policies.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;The participants in this study were medical professionals involved in medical care and prevention integration work. The participants were all from medical institutions of pilot cities for the collaboration and integration of medical care and prevention. The study sample was selected through multi-stage sampling. A questionnaire based on the theoretical framework of the KAP model was designed. Two cross-sectional surveys were conducted-once before the initiation of the pilot program (baseline) and again 12 months after implementation (after implementation). After propensity score matching (PSM), descriptive statistics and hypothesis testing were used to statistically analyze the questionnaire data. In addition, a structural equation model (SEM) was applied to assess the current status and effect pathways of the participants' KAP regarding the integration of medical care and prevention.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;A total of 11472 responses were collected, and 10627 were included in analysis after PSM, including 5007 before the implementation of the policy and 5620 after the implementation of the policy. No significant differences were observed in demographic variables between the two samples. Baseline scores for knowledge, attitude, and practice regarding the integration of medical care and prevention were 13.32 ± 0.05, 15.62 ± 0.04, and 6.37 ± 0.02 respectively, while the scores at the end of the study were 13.69, 15.74, and 6.51, respectively, all show an increase to a certain degree (&lt;i&gt;P&lt;/i&gt; &lt; 0.05). Stratified analysis by institution level revealed relatively significant improvements in knowledge and practice (&lt;i&gt;P&lt;/i&gt; &lt; 0.05), but no significant improvement in attitudes (&lt;i&gt;P&lt;/i&gt; &gt; 0.05) among medical professionals. Medical professionals in primary medical institutions generally demonstrated superior knowledge, attitudes, and practice frequency compared with those in secondary and tertiary hospitals (&lt;i&gt;P&lt;/i&gt; &lt; 0.001). No significant changes in KAP were observed among medical professionals in secondary hospitals (&lt;i&gt;P&lt;/i&gt; &gt; 0.05). Regarding the integration of medical care and prevention, the effect of knowledge on practice (standardized path coefficient = 0.496, 95% CI: 0.482, 0.508) was stronger than that of attitude on practice (standardized path coefficient = 0.267, 95% CI: 0.244, 0.290). The direct effect of knowledge on practice (78.0%) was greater than the indir","PeriodicalId":39321,"journal":{"name":"四川大学学报(医学版)","volume":"56 6","pages":"1498-1505"},"PeriodicalIF":0.0,"publicationDate":"2025-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12796908/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145971319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Interpretation of the Disinfection Effects Testing and Evaluation Methods Section in Test Methods for Disinfection Products (WS/T 10009-2023)]. [对《消毒产品试验方法》(WS/T 10009-2023)《消毒效果试验和评价方法》章节的解释]。
Q3 Medicine Pub Date : 2025-09-20 DOI: 10.12182/20250960102
Yanyan Wang, Jiaqi Wang, Qiuhua Wei, Li Yu, Jin Shen

Test Methods for Disinfection Products (WS/T 10009-2023), a health industry standard, was officially released by the National Disease Control and Prevention Administration on December 15, 2023. The standard came into effect on May 1, 2024. This standard systematically specifies the testing and evaluation methods for disinfection products, covering three core components-disinfection effect testing and evaluation, physical and chemical testing techniques, and toxicological testing methods. The standard provides an important technical basis for the testing of disinfection products in China. To promote an accurate understanding and effective implementation of the standard, this article focuses on the in-depth interpretation of the section concerning the testing and evaluation methods of disinfection effects. It provides a detailed explanation of the major updates, technical highlights, and scientific rationale behind the standard. The article incorporates discussions on optimizing the validation test methods for the disinfection and sterilization effects of disinfectants, simulated field testing of disinfectants, evaluation of air disinfection effects, and the supplementation and improvement of testing methods for disinfection devices (including sterilization devices). This article aims to provide clear technical guidance for disinfection product inspection personnel, researchers, and other professionals involved, promote the standardized application of the standard, improve the quality of disinfection products, and ensure scientific, effective, and safe disinfection practices.

卫生行业标准《消毒产品试验方法》(WS/T 10009-2023)于2023年12月15日由国家疾病预防控制局正式发布。该标准于2024年5月1日起实施。本标准系统地规定了消毒产品的检测与评价方法,涵盖了消毒效果检测与评价、理化检测技术、毒理学检测方法三个核心部分。该标准为中国消毒产品的检测提供了重要的技术依据。为促进标准的准确理解和有效实施,本文重点对消毒效果检测评价方法部分进行了深入解读。它提供了主要更新、技术亮点和标准背后的科学原理的详细解释。本文对消毒剂消毒灭菌效果验证试验方法的优化、消毒剂模拟现场试验、空气消毒效果评价、消毒装置(含灭菌装置)检测方法的补充和完善等进行了探讨。本文旨在为消毒产品检验人员、科研人员及相关专业人员提供明确的技术指导,促进标准的规范应用,提高消毒产品的质量,确保科学、有效、安全的消毒实践。
{"title":"[Interpretation of the Disinfection Effects Testing and Evaluation Methods Section in <i>Test Methods for Disinfection Products (WS/T 10009-2023)</i>].","authors":"Yanyan Wang, Jiaqi Wang, Qiuhua Wei, Li Yu, Jin Shen","doi":"10.12182/20250960102","DOIUrl":"10.12182/20250960102","url":null,"abstract":"<p><p><i>Test Methods for Disinfection Products (WS/T 10009-2023)</i>, a health industry standard, was officially released by the National Disease Control and Prevention Administration on December 15, 2023. The standard came into effect on May 1, 2024. This standard systematically specifies the testing and evaluation methods for disinfection products, covering three core components-disinfection effect testing and evaluation, physical and chemical testing techniques, and toxicological testing methods. The standard provides an important technical basis for the testing of disinfection products in China. To promote an accurate understanding and effective implementation of the standard, this article focuses on the in-depth interpretation of the section concerning the testing and evaluation methods of disinfection effects. It provides a detailed explanation of the major updates, technical highlights, and scientific rationale behind the standard. The article incorporates discussions on optimizing the validation test methods for the disinfection and sterilization effects of disinfectants, simulated field testing of disinfectants, evaluation of air disinfection effects, and the supplementation and improvement of testing methods for disinfection devices (including sterilization devices). This article aims to provide clear technical guidance for disinfection product inspection personnel, researchers, and other professionals involved, promote the standardized application of the standard, improve the quality of disinfection products, and ensure scientific, effective, and safe disinfection practices.</p>","PeriodicalId":39321,"journal":{"name":"四川大学学报(医学版)","volume":"56 5","pages":"1184-1188"},"PeriodicalIF":0.0,"publicationDate":"2025-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12709061/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145782313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Integration of Microbiome Research and the One Health Approach Promotes Innovation and Development in Public Health Laboratory Sciences]. [微生物组研究和同一个健康方法的整合促进了公共卫生实验室科学的创新和发展]。
Q3 Medicine Pub Date : 2025-09-20 DOI: 10.12182/20250960601
Ruifu Yang

As global health challenges become increasingly complex and multidimensional, microbiome research and the One Health approach-along with their integration-actively promote the development of the field of public health laboratory sciences. The microbiome is an essential component of the human body, animals, and the environment. Microbiome research not only elucidates the interaction mechanisms between microorganisms and their hosts but also provides an irreplaceable material basis for the well-being of humans, animals, and the environment, offering new perspectives for the prevention, diagnosis, and treatment of human diseases. Additionally, the One Health approach emphasizes the interconnectedness of human, animal, and environmental health, establishing a theoretical foundation for interdisciplinary collaboration and global health management. The integration of the microbiome and the One Health approach establishes the notion of "the balance of dynamic factors" as a scientific principle underpinning One Health. This integration holds far-reaching implications for expanding new fields and developing new technologies in public health laboratory sciences, as well as informing public health practices.

随着全球卫生挑战变得越来越复杂和多维,微生物组研究和“同一个健康”方法及其整合积极促进了公共卫生实验室科学领域的发展。微生物群是人体、动物和环境的重要组成部分。微生物组研究不仅阐明了微生物与宿主之间的相互作用机制,而且为人类、动物和环境的健康提供了不可替代的物质基础,为人类疾病的预防、诊断和治疗提供了新的视角。此外,“同一个健康”方法强调人类、动物和环境健康的相互联系,为跨学科合作和全球健康管理奠定了理论基础。微生物组和同一健康方法的整合建立了“动态因素平衡”的概念,作为支撑同一健康的科学原则。这种整合对扩大公共卫生实验室科学的新领域和开发新技术以及为公共卫生实践提供信息具有深远的影响。
{"title":"[Integration of Microbiome Research and the One Health Approach Promotes Innovation and Development in Public Health Laboratory Sciences].","authors":"Ruifu Yang","doi":"10.12182/20250960601","DOIUrl":"10.12182/20250960601","url":null,"abstract":"<p><p>As global health challenges become increasingly complex and multidimensional, microbiome research and the One Health approach-along with their integration-actively promote the development of the field of public health laboratory sciences. The microbiome is an essential component of the human body, animals, and the environment. Microbiome research not only elucidates the interaction mechanisms between microorganisms and their hosts but also provides an irreplaceable material basis for the well-being of humans, animals, and the environment, offering new perspectives for the prevention, diagnosis, and treatment of human diseases. Additionally, the One Health approach emphasizes the interconnectedness of human, animal, and environmental health, establishing a theoretical foundation for interdisciplinary collaboration and global health management. The integration of the microbiome and the One Health approach establishes the notion of \"the balance of dynamic factors\" as a scientific principle underpinning One Health. This integration holds far-reaching implications for expanding new fields and developing new technologies in public health laboratory sciences, as well as informing public health practices.</p>","PeriodicalId":39321,"journal":{"name":"四川大学学报(医学版)","volume":"56 5","pages":"1171-1176"},"PeriodicalIF":0.0,"publicationDate":"2025-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12709064/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145783255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[High-Throughput Detection of Multiple Classes of Antibiotics in Source Water Using a Functionalized Polyacrylonitrile Nanofiber Membrane]. 功能化聚丙烯腈纳米纤维膜对水源水中多类抗生素的高通量检测[j]。
Q3 Medicine Pub Date : 2025-09-20 DOI: 10.12182/20250960105
Kai Wang, Qixun Nian, Chunmin Wang, Qiuping Zhang, Qian Xu

Objective: To develop a novel solid-phase extraction (SPE) method based on a functionalized nanofiber membrane for the efficient co-extraction of structurally diverse antibiotics with markedly different physicochemical properties from source water, and to establish a high-throughput analysis method by coupling this technique with ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS).

Methods: A polydopamine and zirconium (Ⅳ) fumarate metal-organic frameworks (MOF-801) co-modified polyacrylonitrile nanofiber membrane (PDA@PAN/MOF-801 NFMs) was prepared as the SPE adsorbent through hybrid electrospinning and dopamine self-polymerization. Critical SPE and UPLC-MS/MS parameters were optimized, and the method was applied to analyze antibiotic contamination in source water samples from 14 sources of centralized drinking water supply in Suzhou, China, to evaluate the practical application potential of the method.

Results: The PDA@PAN/MOF-801 NFMs adsorbent demonstrated efficient adsorption of 32 antibiotics from 6 classes through multiple retention mechanisms, including synergistic electrostatic interactions, hydrogen bonding, and π-π interactions. In combination with UPLC-MS/MS, the SPE method we developed enabled high-throughput detection of multiple antibiotics in source water, with limits of detection (LOD) being 0.001-0.05 ng/L and limits of quantitation (LOQ) being 0.005-500 ng/L. Spiked recoveries were 70.14%-111.50%. Intra-day relative standard deviation (RSD) was below 14.12% and the inter-day RSD was below 15.07%. The method demonstrated excellent sensitivity, accuracy, and precision.

Conclusion: In this study, we successfully developed an efficient analytical method based on a novel nanofiber membrane adsorbent. This approach provides a new technical reference for the high-throughput detection of multiple antibiotics in environmental waters and shows promising potential for practical applications.

目的:建立一种基于功能化纳米纤维膜的新型固相萃取(SPE)方法,用于从水源水中高效共萃取结构多样且理化性质显著不同的抗生素,并将该技术与超高效液相色谱-串联质谱(UPLC-MS/MS)联用,建立一种高通量分析方法。方法:采用复合静电纺丝和多巴胺自聚合法制备聚多巴胺和富马酸锆(Ⅳ)金属有机骨架(MOF-801)共改性聚丙烯腈纳米纤维膜(PDA@PAN/MOF-801 NFMs)作为SPE吸附剂。优化了关键的SPE和UPLC-MS/MS参数,并应用该方法对苏州14个集中供水水源水样中的抗生素污染进行了分析,以评价该方法的实际应用潜力。结果:PDA@PAN/MOF-801 NFMs吸附剂通过协同静电作用、氢键作用和π-π相互作用等多种保留机制,对6类32种抗生素进行了高效吸附。结合UPLC-MS/MS,建立的SPE方法对水源水中多种抗生素进行高通量检测,检出限(LOD)为0.001 ~ 0.05 ng/L,定量限(LOQ)为0.005 ~ 500 ng/L。加标回收率为70.14% ~ 111.50%。日内相对标准偏差(RSD) < 14.12%,日内RSD < 15.07%。该方法具有良好的灵敏度、准确度和精密度。结论:在本研究中,我们成功开发了一种基于新型纳米纤维膜吸附剂的高效分析方法。该方法为环境水体中多种抗生素的高通量检测提供了新的技术参考,具有广阔的实际应用潜力。
{"title":"[High-Throughput Detection of Multiple Classes of Antibiotics in Source Water Using a Functionalized Polyacrylonitrile Nanofiber Membrane].","authors":"Kai Wang, Qixun Nian, Chunmin Wang, Qiuping Zhang, Qian Xu","doi":"10.12182/20250960105","DOIUrl":"10.12182/20250960105","url":null,"abstract":"<p><strong>Objective: </strong>To develop a novel solid-phase extraction (SPE) method based on a functionalized nanofiber membrane for the efficient co-extraction of structurally diverse antibiotics with markedly different physicochemical properties from source water, and to establish a high-throughput analysis method by coupling this technique with ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS).</p><p><strong>Methods: </strong>A polydopamine and zirconium (Ⅳ) fumarate metal-organic frameworks (MOF-801) co-modified polyacrylonitrile nanofiber membrane (PDA@PAN/MOF-801 NFMs) was prepared as the SPE adsorbent through hybrid electrospinning and dopamine self-polymerization. Critical SPE and UPLC-MS/MS parameters were optimized, and the method was applied to analyze antibiotic contamination in source water samples from 14 sources of centralized drinking water supply in Suzhou, China, to evaluate the practical application potential of the method.</p><p><strong>Results: </strong>The PDA@PAN/MOF-801 NFMs adsorbent demonstrated efficient adsorption of 32 antibiotics from 6 classes through multiple retention mechanisms, including synergistic electrostatic interactions, hydrogen bonding, and π-π interactions. In combination with UPLC-MS/MS, the SPE method we developed enabled high-throughput detection of multiple antibiotics in source water, with limits of detection (LOD) being 0.001-0.05 ng/L and limits of quantitation (LOQ) being 0.005-500 ng/L. Spiked recoveries were 70.14%-111.50%. Intra-day relative standard deviation (RSD) was below 14.12% and the inter-day RSD was below 15.07%. The method demonstrated excellent sensitivity, accuracy, and precision.</p><p><strong>Conclusion: </strong>In this study, we successfully developed an efficient analytical method based on a novel nanofiber membrane adsorbent. This approach provides a new technical reference for the high-throughput detection of multiple antibiotics in environmental waters and shows promising potential for practical applications.</p>","PeriodicalId":39321,"journal":{"name":"四川大学学报(医学版)","volume":"56 5","pages":"1197-1207"},"PeriodicalIF":0.0,"publicationDate":"2025-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12709077/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145783158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
四川大学学报(医学版)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1